LYRM4 and non-small cell lung carcinoma: In summary, these findings indicated that LYRM4[T] overexpression confers NSCLC cells with stronger resistance to ferroptosis compared to LYRM4[G] and LYRM4 act as an oncogene promoting the malignant phenotypes of NSCLC cells through suppressing ferroptosis.